08/01/2018 |
VASOTEC NDA #018998 |
SUPPL-83 |
ENALAPRIL MALEATE |
BAUSCH |
Labeling |
Approval |
08/01/2018 |
DEPO-TESTOSTERONE ANDA #085635 |
SUPPL-40 |
TESTOSTERONE CYPIONATE |
PFIZER |
Labeling |
Approval |
08/01/2018 |
ROCURONIUM BROMIDE ANDA #091115 |
SUPPL-9 |
ROCURONIUM BROMIDE |
TAMARANG |
Labeling |
Approval |
08/01/2018 |
OXACILLIN SODIUM ANDA #201539 |
SUPPL-7 |
OXACILLIN SODIUM |
EUGIA PHARMA SPECLTS |
Manufacturing (CMC) |
Approval |
08/01/2018 |
VANCOMYCIN HYDROCHLORIDE ANDA #204125 |
SUPPL-2 |
VANCOMYCIN HYDROCHLORIDE |
XELLIA PHARMS APS |
Labeling |
Approval |
08/01/2018 |
CABERGOLINE ANDA #204735 |
ORIG-1 |
CABERGOLINE |
INGENUS PHARMS LLC |
|
Approval |
08/01/2018 |
GENVOYA NDA #207561 |
SUPPL-17 |
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE |
GILEAD SCIENCES INC |
Labeling |
Approval |
08/01/2018 |
RANITIDINE HYDROCHLORIDE ANDA #210010 |
ORIG-1 |
RANITIDINE HYDROCHLORIDE |
STRIDES PHARMA |
|
Approval |
08/01/2018 |
CINACALCET HYDROCHLORIDE ANDA #210207 |
ORIG-1 |
CINACALCET HYDROCHLORIDE |
SLATE RUN PHARMA |
|
Approval |
08/02/2018 |
ADVIL LIQUI-GELS NDA #020402 |
SUPPL-46 |
IBUPROFEN |
HALEON US HOLDINGS |
Labeling |
Approval |
08/02/2018 |
ADVIL MIGRAINE LIQUI-GELS NDA #020402 |
SUPPL-46 |
IBUPROFEN |
HALEON US HOLDINGS |
Labeling |
Approval |
08/02/2018 |
VALCYTE NDA #021304 |
SUPPL-14 |
VALGANCICLOVIR HYDROCHLORIDE |
CHEPLAPHARM |
Efficacy |
Approval |
08/02/2018 |
DOCETAXEL NDA #022234 |
SUPPL-10 |
DOCETAXEL |
HOSPIRA INC |
Labeling |
Approval |
08/02/2018 |
VALCYTE NDA #022257 |
SUPPL-9 |
VALGANCICLOVIR HYDROCHLORIDE |
CHEPLAPHARM |
Efficacy |
Approval |
08/02/2018 |
HUMIRA BLA #125057 |
SUPPL-406 |
ADALIMUMAB |
ABBVIE INC |
|
Approval |
08/02/2018 |
METHADONE HYDROCHLORIDE ANDA #210484 |
ORIG-1 |
METHADONE HYDROCHLORIDE |
NOSTRUM LABS INC |
|
Approval |
08/02/2018 |
TIGECYCLINE NDA #211158 |
ORIG-1 |
TIGECYCLINE |
AMNEAL |
Type 5 - New Formulation or New Manufacturer |
Approval |
08/03/2018 |
TADALAFIL ANDA #200630 |
ORIG-1 |
TADALAFIL |
MYLAN |
|
Approval |
08/03/2018 |
STENDRA NDA #202276 |
SUPPL-18 |
AVANAFIL |
METUCHEN PHARMS |
Efficacy |
Approval |
08/03/2018 |
NUVESSA NDA #205223 |
SUPPL-2 |
METRONIDAZOLE |
CHEMO RESEARCH SL |
Efficacy |
Approval |
08/03/2018 |
JADENU NDA #206910 |
SUPPL-10 |
DEFERASIROX |
NOVARTIS PHARMS CORP |
Labeling |
Approval |
08/03/2018 |
JADENU SPRINKLE NDA #207968 |
SUPPL-5 |
DEFERASIROX |
NOVARTIS |
Labeling |
Approval |
08/03/2018 |
LIDOCAINE HYDROCHLORIDE ANDA #208474 |
ORIG-1 |
LIDOCAINE HYDROCHLORIDE |
B BRAUN MEDICAL INC |
|
Approval |
08/03/2018 |
DICLOFENAC SODIUM ANDA #209903 |
ORIG-1 |
DICLOFENAC SODIUM |
CIPLA |
|
Approval |
08/06/2018 |
GALLIUM CITRATE GA 67 NDA #017478 |
SUPPL-16 |
GALLIUM CITRATE GA-67 |
LANTHEUS MEDCL |
Labeling |
Approval |
08/06/2018 |
CYTOVENE NDA #019661 |
SUPPL-37 |
GANCICLOVIR SODIUM |
CHEPLAPHARM |
Efficacy |
Approval |
08/06/2018 |
PRIMAXIN NDA #050587 |
SUPPL-80 |
CILASTATIN SODIUM; IMIPENEM |
MERCK |
Manufacturing (CMC) |
Approval |
08/06/2018 |
ROFLUMILAST ANDA #208272 |
ORIG-1 |
ROFLUMILAST |
TORRENT |
|
Approval |
08/06/2018 |
MAVYRET NDA #209394 |
SUPPL-2 |
GLECAPREVIR; PIBRENTASVIR |
ABBVIE |
Efficacy |
Approval |
08/07/2018 |
KETALAR NDA #016812 |
SUPPL-40 |
KETAMINE HYDROCHLORIDE |
PAR STERILE PRODUCTS |
Labeling |
Approval |
08/07/2018 |
STRIBILD NDA #203100 |
SUPPL-32 |
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
GILEAD SCIENCES INC |
Labeling |
Approval |
08/07/2018 |
TOLCAPONE ANDA #208937 |
ORIG-1 |
TOLCAPONE |
NOVAST LABS |
|
Approval |
08/07/2018 |
AXITINIB ANDA #210234 |
ORIG-1 |
AXITINIB |
TEVA PHARMS |
|
Tentative Approval |
08/07/2018 |
ORKAMBI NDA #211358 |
ORIG-1 |
IVACAFTOR; LUMACAFTOR |
VERTEX PHARMS INC |
Type 3 - New Dosage Form |
Approval |
08/08/2018 |
LASIX NDA #016273 |
SUPPL-69 |
FUROSEMIDE |
VALIDUS PHARMS |
Labeling |
Approval |
08/08/2018 |
BUMEX NDA #018225 |
SUPPL-28 |
BUMETANIDE |
VALIDUS PHARMS |
Labeling |
Approval |
08/08/2018 |
LOTENSIN HCT NDA #020033 |
SUPPL-62 |
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
VALIDUS PHARMS |
Labeling |
Approval |
08/08/2018 |
SOLUPREP S NDA #208288 |
ORIG-1 |
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL |
3M HEALTH CARE |
Type 5 - New Formulation or New Manufacturer |
Approval |
08/08/2018 |
JORNAY PM NDA #209311 |
ORIG-1 |
METHYLPHENIDATE HYDROCHLORIDE |
IRONSHORE PHARMS |
Type 3 - New Dosage Form |
Approval |
08/08/2018 |
ARAKODA NDA #210607 |
ORIG-1 |
TAFENOQUINE SUCCINATE |
60 DEGREES PHARMS |
Type 5 - New Formulation or New Manufacturer |
Approval |
08/08/2018 |
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE NDA #210880 |
ORIG-1 |
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE |
HETERO LABS UNIT III |
Type 4 - New Combination |
Tentative Approval |
08/08/2018 |
POTASSIUM CHLORIDE ANDA #211067 |
ORIG-1 |
POTASSIUM CHLORIDE |
APOTEX |
|
Approval |
08/08/2018 |
POTELIGEO BLA #761051 |
ORIG-1 |
MOGAMULIZUMAB-KPKC |
KYOWA KIRIN |
|
Approval |
08/09/2018 |
ATAZANAVIR SULFATE ANDA #200626 |
ORIG-1 |
ATAZANAVIR SULFATE |
CIPLA |
|
Approval |
08/09/2018 |
DICLOFENAC SODIUM ANDA #202769 |
SUPPL-1 |
DICLOFENAC SODIUM |
PAI HOLDINGS PHARM |
Labeling |
Approval |
08/09/2018 |
RYZODEG 70/30 BLA #203313 |
SUPPL-5 |
INSULIN ASPART; INSULIN DEGLUDEC |
NOVO |
|
Approval |
08/09/2018 |
TRESIBA BLA #203314 |
SUPPL-9 |
INSULIN DEGLUDEC |
NOVO |
|
Approval |
08/09/2018 |
METHOTREXATE SODIUM PRESERVATIVE FREE ANDA #203407 |
ORIG-1 |
METHOTREXATE SODIUM |
SAGENT PHARMS INC |
|
Approval |
08/09/2018 |
MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE ANDA #208328 |
SUPPL-1 |
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE |
AMNEAL PHARMS |
Manufacturing (CMC) |
Tentative Approval |
08/09/2018 |
NETSPOT NDA #208547 |
SUPPL-13 |
GALLIUM DOTATATE GA-68 |
AAA USA INC |
Manufacturing (CMC) |
Approval |
08/09/2018 |
ESTRADIOL ANDA #210194 |
SUPPL-2 |
ESTRADIOL |
PADAGIS ISRAEL |
Labeling |
Approval |
08/09/2018 |
ESTRADIOL ANDA #210488 |
SUPPL-1 |
ESTRADIOL |
TEVA PHARMS USA |
Labeling |
Approval |
08/09/2018 |
LARTRUVO BLA #761038 |
SUPPL-9 |
OLARATUMAB |
ELI LILLY AND CO |
|
Approval |
08/10/2018 |
HIBICLENS NDA #017768 |
SUPPL-48 |
CHLORHEXIDINE GLUCONATE |
MOLNLYCKE HLTH |
Manufacturing (CMC) |
Approval |
08/10/2018 |
GLUCOTROL XL NDA #020329 |
SUPPL-32 |
GLIPIZIDE |
PFIZER |
Labeling |
Approval |
08/10/2018 |
LIPITOR NDA #020702 |
SUPPL-71 |
ATORVASTATIN CALCIUM |
UPJOHN |
Labeling |
Approval |
08/10/2018 |
NICORETTE NDA #021330 |
SUPPL-21 |
NICOTINE POLACRILEX |
HALEON US HOLDINGS |
Manufacturing (CMC) |
Approval |
08/10/2018 |
ZORTRESS NDA #021560 |
SUPPL-22 |
EVEROLIMUS |
NOVARTIS |
Manufacturing (CMC) |
Approval |
08/10/2018 |
NEXIUM IV NDA #021689 |
SUPPL-33 |
ESOMEPRAZOLE SODIUM |
ASTRAZENECA |
Labeling |
Approval |
08/10/2018 |
MOMETASONE FUROATE ANDA #078541 |
SUPPL-11 |
MOMETASONE FUROATE |
GLENMARK PHARMS INC |
Labeling |
Approval |
08/10/2018 |
INLYTA NDA #202324 |
SUPPL-8 |
AXITINIB |
PF PRISM CV |
Labeling |
Approval |
08/10/2018 |
PIPERACILLIN AND TAZOBACTAM ANDA #204959 |
ORIG-1 |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
SHANDONG |
|
Approval |
08/10/2018 |
AKOVAZ NDA #208289 |
SUPPL-2 |
EPHEDRINE SULFATE |
EXELA PHARMA |
Labeling |
Approval |
08/10/2018 |
GALAFOLD NDA #208623 |
ORIG-1 |
MIGALASTAT HYDROCHLORIDE |
AMICUS THERAP US |
Type 1 - New Molecular Entity |
Approval |
08/10/2018 |
INGREZZA NDA #209241 |
SUPPL-3 |
VALBENAZINE TOSYLATE |
NEUROCRINE |
Labeling |
Approval |
08/10/2018 |
SODIUM NITROPRUSSIDE ANDA #209584 |
ORIG-1 |
SODIUM NITROPRUSSIDE |
MYLAN |
|
Approval |
08/10/2018 |
ANNOVERA NDA #209627 |
ORIG-1 |
ETHINYL ESTRADIOL; SEGESTERONE ACETATE |
MAYNE PHARMA |
Type 1 - New Molecular Entity and Type 4 - New Combination |
Approval |
08/10/2018 |
ONPATTRO NDA #210922 |
ORIG-1 |
PATISIRAN SODIUM |
ALNYLAM PHARMS INC |
Type 1 - New Molecular Entity |
Approval |
08/13/2018 |
VENLAFAXINE HYDROCHLORIDE ANDA #204889 |
SUPPL-1 |
VENLAFAXINE HYDROCHLORIDE |
MACLEODS PHARMS LTD |
Labeling |
Approval |
08/13/2018 |
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE NDA #205626 |
ORIG-1 |
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE |
MICRO LABS |
Type 4 - New Combination |
Approval |
08/13/2018 |
IMATINIB MESYLATE ANDA #206547 |
ORIG-1 |
IMATINIB MESYLATE |
DR REDDYS |
|
Approval |
08/13/2018 |
FEXOFENADINE HYDROCHLORIDE ALLERGY ANDA #210137 |
ORIG-1 |
FEXOFENADINE HYDROCHLORIDE |
UNIQUE |
|
Approval |
08/14/2018 |
CYRAMZA BLA #125477 |
SUPPL-30 |
RAMUCIRUMAB |
ELI LILLY AND CO |
|
Approval |
08/14/2018 |
ESTRADIOL ANDA #201675 |
SUPPL-5 |
ESTRADIOL |
MYLAN TECHNOLOGIES |
Labeling |
Approval |
08/14/2018 |
ESTRADIOL ANDA #201675 |
SUPPL-6 |
ESTRADIOL |
MYLAN TECHNOLOGIES |
Labeling |
Approval |
08/14/2018 |
CEQUA NDA #210913 |
ORIG-1 |
CYCLOSPORINE |
SUN PHARM |
Type 5 - New Formulation or New Manufacturer |
Approval |
08/15/2018 |
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE NDA #022343 |
ORIG-1 |
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE |
AUROBINDO PHARMA LTD |
Type 4 - New Combination |
Approval |
08/15/2018 |
HYDROCODONE BITARTRATE AND ACETAMINOPHEN ANDA #040432 |
SUPPL-10 |
ACETAMINOPHEN; HYDROCODONE BITARTRATE |
CHARTWELL |
Labeling |
Approval |
08/15/2018 |
HYDROCODONE BITARTRATE AND ACETAMINOPHEN ANDA #040482 |
SUPPL-18 |
ACETAMINOPHEN; HYDROCODONE BITARTRATE |
CHARTWELL |
Labeling |
Approval |
08/15/2018 |
COSMEGEN NDA #050682 |
SUPPL-33 |
DACTINOMYCIN |
RECORDATI RARE |
Efficacy |
Approval |
08/15/2018 |
COSMEGEN NDA #050682 |
SUPPL-34 |
DACTINOMYCIN |
RECORDATI RARE |
Efficacy |
Approval |
08/15/2018 |
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE ANDA #074736 |
SUPPL-32 |
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE |
WATSON LABS |
Labeling |
Approval |
08/15/2018 |
HYDROCODONE BITARTRATE AND IBUPROFEN ANDA #076642 |
SUPPL-20 |
HYDROCODONE BITARTRATE; IBUPROFEN |
AMNEAL PHARMS NY |
Labeling |
Approval |
08/15/2018 |
HYDROCODONE BITARTRATE AND IBUPROFEN ANDA #076642 |
SUPPL-22 |
HYDROCODONE BITARTRATE; IBUPROFEN |
AMNEAL PHARMS NY |
Labeling |
Approval |
08/15/2018 |
HYDROCODONE BITARTRATE AND IBUPROFEN ANDA #076642 |
SUPPL-23 |
HYDROCODONE BITARTRATE; IBUPROFEN |
AMNEAL PHARMS NY |
Labeling |
Approval |
08/15/2018 |
REPREXAIN ANDA #076642 |
SUPPL-20 |
HYDROCODONE BITARTRATE; IBUPROFEN |
AMNEAL PHARMS NY |
Labeling |
Approval |
08/15/2018 |
REPREXAIN ANDA #076642 |
SUPPL-22 |
HYDROCODONE BITARTRATE; IBUPROFEN |
AMNEAL PHARMS NY |
Labeling |
Approval |
08/15/2018 |
REPREXAIN ANDA #076642 |
SUPPL-23 |
HYDROCODONE BITARTRATE; IBUPROFEN |
AMNEAL PHARMS NY |
Labeling |
Approval |
08/15/2018 |
HYDROCODONE BITARTRATE AND IBUPROFEN ANDA #077454 |
SUPPL-1 |
HYDROCODONE BITARTRATE; IBUPROFEN |
ANI PHARMS |
Labeling |
Approval |
08/15/2018 |
OXYCODONE HYDROCHLORIDE AND IBUPROFEN ANDA #078769 |
SUPPL-20 |
IBUPROFEN; OXYCODONE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
08/15/2018 |
ESTRACE ANDA #086069 |
SUPPL-24 |
ESTRADIOL |
ALLERGAN |
Labeling |
Approval |
08/15/2018 |
PREPOPIK NDA #202535 |
SUPPL-5 |
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE |
FERRING PHARMS INC |
Efficacy |
Approval |
08/15/2018 |
KALYDECO NDA #203188 |
SUPPL-28 |
IVACAFTOR |
VERTEX PHARMS |
Efficacy |
Approval |
08/15/2018 |
HYDROCODONE BITARTRATE AND IBUPROFEN ANDA #204575 |
SUPPL-1 |
HYDROCODONE BITARTRATE; IBUPROFEN |
AUROLIFE PHARMA LLC |
Labeling |
Approval |
08/15/2018 |
ATRACURIUM BESYLATE ANDA #206011 |
SUPPL-2 |
ATRACURIUM BESYLATE |
EUGIA PHARMA |
Labeling |
Approval |
08/15/2018 |
ORKAMBI NDA #206038 |
SUPPL-10 |
IVACAFTOR; LUMACAFTOR |
VERTEX PHARMS INC |
Labeling |
Approval |
08/15/2018 |
ESTRADIOL ANDA #206685 |
ORIG-1 |
ESTRADIOL |
MYLAN TECHNOLOGIES |
|
Approval |
08/15/2018 |
LENVIMA NDA #206947 |
SUPPL-7 |
LENVATINIB MESYLATE |
EISAI INC |
Efficacy |
Approval |
08/15/2018 |
KALYDECO NDA #207925 |
SUPPL-7 |
IVACAFTOR |
VERTEX PHARMS INC |
Efficacy |
Approval |
08/15/2018 |
ESTRADIOL ANDA #209767 |
SUPPL-1 |
ESTRADIOL |
ALVOGEN |
Labeling |
Approval |
08/16/2018 |
ABRAXANE NDA #021660 |
SUPPL-45 |
PACLITAXEL |
BRISTOL-MYERS |
Labeling |
Approval |
08/16/2018 |
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE ANDA #076631 |
SUPPL-32 |
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
SANDOZ |
Labeling |
Approval |
08/16/2018 |
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE ANDA #076688 |
SUPPL-15 |
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
AUROBINDO PHARMA USA |
Labeling |
Approval |
08/16/2018 |
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE ANDA #078794 |
SUPPL-4 |
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
APOTEX |
Labeling |
Approval |
08/16/2018 |
EPINEPHRINE (AUTOINJECTOR) ANDA #090589 |
ORIG-1 |
EPINEPHRINE |
TEVA PHARMS USA |
|
Approval |
08/16/2018 |
EYLEA BLA #125387 |
SUPPL-56 |
AFLIBERCEPT |
REGENERON PHARMACEUTICALS |
|
Approval |
08/16/2018 |
EYLEA BLA #125387 |
SUPPL-58 |
AFLIBERCEPT |
REGENERON PHARMACEUTICALS |
|
Approval |
08/16/2018 |
KEYTRUDA BLA #125514 |
SUPPL-46 |
PEMBROLIZUMAB |
MERCK SHARP DOHME |
|
Approval |
08/16/2018 |
OPDIVO BLA #125554 |
SUPPL-67 |
NIVOLUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
08/16/2018 |
LOPINAVIR; RITONAVIR NDA #210540 |
ORIG-1 |
LOPINAVIR; RITONAVIR |
MYLAN LABS LTD |
Type 5 - New Formulation or New Manufacturer |
Tentative Approval |
08/16/2018 |
KETOROLAC TROMETHAMINE ANDA #210616 |
ORIG-1 |
KETOROLAC TROMETHAMINE |
CHARTWELL RX |
|
Approval |
08/17/2018 |
MIRALAX NDA #022015 |
SUPPL-33 |
POLYETHYLENE GLYCOL 3350 |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
08/17/2018 |
DIVIGEL NDA #022038 |
SUPPL-4 |
ESTRADIOL |
VERTICAL PHARMS |
Efficacy |
Approval |
08/17/2018 |
XELJANZ NDA #203214 |
SUPPL-21 |
TOFACITINIB CITRATE |
PF PRISM CV |
Labeling |
Approval |
08/17/2018 |
PACLITAXEL ANDA #205720 |
ORIG-1 |
PACLITAXEL |
ACCORD HLTHCARE |
|
Approval |
08/17/2018 |
XELJANZ XR NDA #208246 |
SUPPL-7 |
TOFACITINIB CITRATE |
PFIZER |
Labeling |
Approval |
08/17/2018 |
VERZENIO NDA #208716 |
SUPPL-1 |
ABEMACICLIB |
ELI LILLY AND CO |
Labeling |
Approval |
08/17/2018 |
RADICAVA NDA #209176 |
SUPPL-5 |
EDARAVONE |
MITSUBISHI TANABE |
Manufacturing (CMC) |
Approval |
08/17/2018 |
IBUPROFEN ANDA #210149 |
ORIG-1 |
IBUPROFEN |
GUARDIAN DRUG |
|
Approval |
08/17/2018 |
HYDROCORTISONE BUTYRATE ANDA #210209 |
ORIG-1 |
HYDROCORTISONE BUTYRATE |
LUPIN LTD |
|
Approval |
08/17/2018 |
FENOFIBRATE ANDA #210606 |
ORIG-1 |
FENOFIBRATE |
GRAVITI PHARMS |
|
Approval |
08/17/2018 |
SODIUM NITROPRUSSIDE ANDA #210882 |
ORIG-1 |
SODIUM NITROPRUSSIDE |
SOMERSET THERAPS LLC |
|
Approval |
08/20/2018 |
FROVA NDA #021006 |
SUPPL-22 |
FROVATRIPTAN SUCCINATE |
ENDO PHARMS |
Labeling |
Approval |
08/20/2018 |
KEYTRUDA BLA #125514 |
SUPPL-35 |
PEMBROLIZUMAB |
MERCK SHARP DOHME |
|
Approval |
08/20/2018 |
DIACOMIT NDA #206709 |
ORIG-1 |
STIRIPENTOL |
BIOCODEX SA |
Type 1 - New Molecular Entity |
Approval |
08/20/2018 |
DIACOMIT NDA #207223 |
ORIG-1 |
STIRIPENTOL |
BIOCODEX SA |
Type 3 - New Dosage Form |
Approval |
08/20/2018 |
PARSABIV NDA #208325 |
SUPPL-1 |
ETELCALCETIDE |
KAI PHARMS INC |
Labeling |
Approval |
08/20/2018 |
RANITIDINE HYDROCHLORIDE ANDA #210243 |
ORIG-1 |
RANITIDINE HYDROCHLORIDE |
GRANULES |
|
Approval |
08/21/2018 |
PROGESTERONE NDA #017362 |
SUPPL-111 |
PROGESTERONE |
ACTAVIS LABS UT INC |
Labeling |
Approval |
08/21/2018 |
SABRIL NDA #020427 |
SUPPL-18 |
VIGABATRIN |
LUNDBECK PHARMS LLC |
Labeling |
Approval |
08/21/2018 |
GLEEVEC NDA #021588 |
SUPPL-53 |
IMATINIB MESYLATE |
NOVARTIS |
Labeling |
Approval |
08/21/2018 |
SABRIL NDA #022006 |
SUPPL-20 |
VIGABATRIN |
LUNDBECK PHARMS LLC |
Labeling |
Approval |
08/21/2018 |
PRILOSEC NDA #022056 |
SUPPL-21 |
OMEPRAZOLE MAGNESIUM |
COVIS |
Labeling |
Approval |
08/21/2018 |
TASIGNA NDA #022068 |
SUPPL-29 |
NILOTINIB HYDROCHLORIDE |
NOVARTIS |
Labeling |
Approval |
08/21/2018 |
DEXMEDETOMIDINE HYDROCHLORIDE ANDA #208532 |
ORIG-1 |
DEXMEDETOMIDINE HYDROCHLORIDE |
BAXTER HLTHCARE CORP |
|
Approval |
08/21/2018 |
ASPIRIN AND DIPYRIDAMOLE ANDA #208572 |
ORIG-1 |
ASPIRIN; DIPYRIDAMOLE |
SUN PHARM |
|
Approval |
08/21/2018 |
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER ANDA #209408 |
ORIG-1 |
CEFEPIME HYDROCHLORIDE |
SAMSON MEDCL |
|
Approval |
08/21/2018 |
CLOBETASOL PROPIONATE ANDA #210551 |
ORIG-1 |
CLOBETASOL PROPIONATE |
AMNEAL |
|
Approval |
08/21/2018 |
FLUOCINONIDE ANDA #210554 |
ORIG-1 |
FLUOCINONIDE |
AMNEAL |
|
Approval |
08/22/2018 |
SOMA NDA #011792 |
SUPPL-48 |
CARISOPRODOL |
MYLAN SPECIALITY LP |
Labeling |
Approval |
08/22/2018 |
ANAFRANIL NDA #019906 |
SUPPL-41 |
CLOMIPRAMINE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
08/22/2018 |
DANAZOL ANDA #074582 |
SUPPL-31 |
DANAZOL |
BARR |
Labeling |
Approval |
08/22/2018 |
DANAZOL ANDA #077246 |
SUPPL-14 |
DANAZOL |
LANNETT CO INC |
Labeling |
Approval |
08/22/2018 |
PRALUENT BLA #125559 |
SUPPL-14 |
ALIROCUMAB |
REGENERON PHARMACEUTICALS |
|
Approval |
08/22/2018 |
DIPHENHYDRAMINE HYDROCHLORIDE ANDA #205723 |
ORIG-1 |
DIPHENHYDRAMINE HYDROCHLORIDE |
MICRO LABS |
|
Approval |
08/22/2018 |
LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #206473 |
SUPPL-2 |
LINEZOLID |
HOSPIRA |
Labeling |
Approval |
08/22/2018 |
IRESSA NDA #206995 |
SUPPL-3 |
GEFITINIB |
ASTRAZENECA |
Labeling |
Approval |
08/22/2018 |
GLEOLAN NDA #208630 |
SUPPL-3 |
AMINOLEVULINIC ACID HYDROCHLORIDE |
NXDC |
Labeling |
Approval |
08/22/2018 |
DEXAMETHASONE SODIUM PHOSPHATE ANDA #208689 |
ORIG-1 |
DEXAMETHASONE SODIUM PHOSPHATE |
AMNEAL |
|
Approval |
08/22/2018 |
DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE ANDA #208690 |
ORIG-1 |
DEXAMETHASONE SODIUM PHOSPHATE |
AMNEAL |
|
Approval |
08/22/2018 |
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE ANDA #209721 |
ORIG-1 |
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
AMNEAL PHARMS CO |
|
Approval |
08/22/2018 |
INVELTYS NDA #210565 |
ORIG-1 |
LOTEPREDNOL ETABONATE |
ALCON LABS INC |
Type 5 - New Formulation or New Manufacturer |
Approval |
08/22/2018 |
NEOSTIGMINE METHYLSULFATE ANDA #210989 |
ORIG-1 |
NEOSTIGMINE METHYLSULFATE |
AMRING PHARMS |
|
Approval |
08/22/2018 |
OXERVATE BLA #761094 |
ORIG-1 |
CENEGERMIN-BKBJ |
DOMPE FARMACEUTICI |
|
Approval |
08/23/2018 |
EPI E Z PEN JR NDA #019430 |
SUPPL-74 |
EPINEPHRINE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
08/23/2018 |
EPIPEN NDA #019430 |
SUPPL-74 |
EPINEPHRINE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
08/23/2018 |
EPIPEN E Z PEN NDA #019430 |
SUPPL-74 |
EPINEPHRINE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
08/23/2018 |
EPIPEN JR. NDA #019430 |
SUPPL-74 |
EPINEPHRINE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
08/23/2018 |
CELLCEPT NDA #050722 |
SUPPL-35 |
MYCOPHENOLATE MOFETIL |
ROCHE PALO |
Labeling |
Approval |
08/23/2018 |
CELLCEPT NDA #050723 |
SUPPL-35 |
MYCOPHENOLATE MOFETIL |
ROCHE PALO |
Labeling |
Approval |
08/23/2018 |
CELLCEPT NDA #050758 |
SUPPL-33 |
MYCOPHENOLATE MOFETIL HYDROCHLORIDE |
ROCHE PALO |
Labeling |
Approval |
08/23/2018 |
CELLCEPT NDA #050759 |
SUPPL-41 |
MYCOPHENOLATE MOFETIL |
ROCHE PALO |
Labeling |
Approval |
08/23/2018 |
TICAGRELOR ANDA #208539 |
ORIG-1 |
TICAGRELOR |
MICRO LABS LTD |
|
Tentative Approval |
08/23/2018 |
ALTRENO NDA #209353 |
ORIG-1 |
TRETINOIN |
DOW PHARM |
Type 3 - New Dosage Form |
Approval |
08/23/2018 |
TAKHZYRO BLA #761090 |
ORIG-1 |
LANADELUMAB-FLYO |
DYAX CORP. |
|
Approval |
08/24/2018 |
LANOXIN NDA #009330 |
SUPPL-34 |
DIGOXIN |
COVIS |
Labeling |
Approval |
08/24/2018 |
LANOXIN PEDIATRIC NDA #009330 |
SUPPL-34 |
DIGOXIN |
COVIS |
Labeling |
Approval |
08/24/2018 |
LANOXIN NDA #020405 |
SUPPL-14 |
DIGOXIN |
CONCORDIA |
Labeling |
Approval |
08/24/2018 |
DIGOXIN NDA #021648 |
SUPPL-11 |
DIGOXIN |
HIKMA |
Labeling |
Approval |
08/24/2018 |
ESTRADIOL ANDA #040197 |
SUPPL-27 |
ESTRADIOL |
BARR LABS INC |
Labeling |
Approval |
08/24/2018 |
OXYCODONE AND ACETAMINOPHEN ANDA #040608 |
SUPPL-12 |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE |
MIKART |
Labeling |
Approval |
08/24/2018 |
HYDROCODONE BITARTRATE AND ACETAMINOPHEN ANDA #040658 |
SUPPL-11 |
ACETAMINOPHEN; HYDROCODONE BITARTRATE |
CHARTWELL |
Labeling |
Approval |
08/24/2018 |
HYDROCODONE BITARTRATE AND ACETAMINOPHEN ANDA #040846 |
SUPPL-10 |
ACETAMINOPHEN; HYDROCODONE BITARTRATE |
MIKART |
Labeling |
Approval |
08/24/2018 |
HYDROCODONE BITARTRATE AND ACETAMINOPHEN ANDA #040881 |
SUPPL-9 |
ACETAMINOPHEN; HYDROCODONE BITARTRATE |
MIKART |
Labeling |
Approval |
08/24/2018 |
CEFOTETAN ANDA #065374 |
SUPPL-8 |
CEFOTETAN DISODIUM |
FRESENIUS KABI USA |
Manufacturing (CMC) |
Approval |
08/24/2018 |
TRAMADOL HYDROCHLORIDE ANDA #200503 |
SUPPL-6 |
TRAMADOL HYDROCHLORIDE |
LUPIN LTD |
Labeling |
Approval |
08/24/2018 |
TRAMADOL HYDROCHLORIDE ANDA #205257 |
SUPPL-5 |
TRAMADOL HYDROCHLORIDE |
MYLAN |
Labeling |
Approval |
08/24/2018 |
IMBRUVICA NDA #205552 |
SUPPL-24 |
IBRUTINIB |
PHARMACYCLICS LLC |
Efficacy |
Approval |
08/24/2018 |
IMBRUVICA NDA #205552 |
SUPPL-25 |
IBRUTINIB |
PHARMACYCLICS LLC |
Labeling |
Approval |
08/24/2018 |
IBUPROFEN ANDA #209207 |
SUPPL-4 |
IBUPROFEN |
TARO |
Manufacturing (CMC) |
Approval |
08/24/2018 |
GABAPENTIN ANDA #209306 |
ORIG-1 |
GABAPENTIN |
LUPIN LTD |
|
Approval |
08/24/2018 |
ITRACONAZOLE ANDA #209460 |
ORIG-1 |
ITRACONAZOLE |
TORRENT |
|
Approval |
08/24/2018 |
DOCETAXEL ANDA #209634 |
ORIG-1 |
DOCETAXEL |
MEITHEAL |
|
Approval |
08/24/2018 |
IMBRUVICA NDA #210563 |
SUPPL-1 |
IBRUTINIB |
PHARMACYCLICS LLC |
Efficacy |
Approval |
08/24/2018 |
OXYGEN, USP NDA #212314 |
ORIG-1 |
OXYGEN |
UNIVERSAL INDUSTRIAL GASES, INC |
Medical Gas |
Approval |
08/24/2018 |
NITROGEN, NF NDA #212315 |
ORIG-1 |
NITROGEN, NF |
UNIVERSAL INDUSTRIAL GASES, INC |
Medical Gas |
Approval |
08/26/2018 |
CARBATROL NDA #020712 |
SUPPL-36 |
CARBAMAZEPINE |
TAKEDA PHARMS USA |
Labeling |
Approval |
08/27/2018 |
CEFOTETAN ANDA #065374 |
SUPPL-4 |
CEFOTETAN DISODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
08/27/2018 |
OCTREOTIDE ACETATE (PRESERVATIVE FREE) ANDA #076313 |
SUPPL-12 |
OCTREOTIDE ACETATE |
WEST-WARD PHARMS INT |
Labeling |
Approval |
08/27/2018 |
OCTREOTIDE ACETATE (PRESERVATIVE FREE) ANDA #076313 |
SUPPL-13 |
OCTREOTIDE ACETATE |
WEST-WARD PHARMS INT |
Manufacturing (CMC) |
Approval |
08/27/2018 |
OCTREOTIDE ACETATE ANDA #076330 |
SUPPL-13 |
OCTREOTIDE ACETATE |
WEST-WARD PHARMS INT |
Labeling |
Approval |
08/27/2018 |
ESTRADIOL ANDA #208788 |
SUPPL-2 |
ESTRADIOL |
MYLAN |
Labeling |
Approval |
08/27/2018 |
METFORMIN HYDROCHLORIDE ANDA #209882 |
ORIG-1 |
METFORMIN HYDROCHLORIDE |
LAURUS |
|
Approval |
08/27/2018 |
XERAVA NDA #211109 |
ORIG-1 |
ERAVACYCLINE DIHYDROCHLORIDE |
TETRAPHASE PHARMS |
Type 1 - New Molecular Entity |
Approval |
08/28/2018 |
ALEVE NDA #020204 |
SUPPL-58 |
NAPROXEN SODIUM |
BAYER |
Labeling |
Approval |
08/28/2018 |
ARIPIPRAZOLE ANDA #090165 |
ORIG-1 |
ARIPIPRAZOLE |
SQUARE PHARMS |
|
Approval |
08/28/2018 |
LOSARTAN POTASSIUM ANDA #201170 |
SUPPL-9 |
LOSARTAN POTASSIUM |
JUBILANT CADISTA |
Manufacturing (CMC) |
Approval |
08/28/2018 |
GEMFIBROZIL ANDA #204189 |
ORIG-1 |
GEMFIBROZIL |
CADILA |
|
Approval |
08/28/2018 |
LEUPROLIDE ACETATE FOR DEPOT SUSPENSION NDA #205054 |
ORIG-1 |
LEUPROLIDE ACETATE |
INVAGEN PHARMS |
Type 5 - New Formulation or New Manufacturer |
Approval |
08/28/2018 |
ALEVE PM NDA #205352 |
SUPPL-11 |
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM |
BAYER HLTHCARE |
Labeling |
Approval |
08/28/2018 |
TAGRISSO NDA #208065 |
SUPPL-11 |
OSIMERTINIB MESYLATE |
ASTRAZENECA |
Labeling |
Approval |
08/28/2018 |
ALOGLIPTIN ANDA #210240 |
ORIG-1 |
ALOGLIPTIN |
HETERO USA INC |
|
Tentative Approval |
08/28/2018 |
FENOFIBRATE ANDA #211080 |
ORIG-1 |
FENOFIBRATE |
PRINSTON INC |
|
Approval |
08/29/2018 |
ADRENACLICK NDA #020800 |
SUPPL-35 |
EPINEPHRINE |
IMPAX |
Labeling |
Approval |
08/29/2018 |
TWINJECT 0.15 NDA #020800 |
SUPPL-35 |
EPINEPHRINE |
IMPAX |
Labeling |
Approval |
08/29/2018 |
TWINJECT 0.3 NDA #020800 |
SUPPL-35 |
EPINEPHRINE |
IMPAX |
Labeling |
Approval |
08/29/2018 |
VUSION NDA #021026 |
SUPPL-13 |
MICONAZOLE NITRATE; WHITE PETROLATUM; ZINC OXIDE |
MYLAN |
Labeling |
Approval |
08/29/2018 |
LAMIVUDINE AND ZIDOVUDINE ANDA #090679 |
ORIG-1 |
LAMIVUDINE; ZIDOVUDINE |
MACLEODS PHARMS LTD |
|
Approval |
08/29/2018 |
CERDELGA NDA #205494 |
SUPPL-3 |
ELIGLUSTAT TARTRATE |
GENZYME CORP |
Efficacy |
Approval |
08/29/2018 |
POTASSIUM CHLORIDE ANDA #209786 |
ORIG-1 |
POTASSIUM CHLORIDE |
NOVEL LABS INC |
|
Approval |
08/29/2018 |
ISOSORBIDE MONONITRATE ANDA #210822 |
ORIG-1 |
ISOSORBIDE MONONITRATE |
DEXCEL LTD |
|
Approval |
08/30/2018 |
CHILDREN'S ADVIL NDA #020589 |
SUPPL-37 |
IBUPROFEN |
HALEON US HOLDINGS |
Labeling |
Approval |
08/30/2018 |
CHILDREN'S ADVIL-FLAVORED NDA #020589 |
SUPPL-37 |
IBUPROFEN |
HALEON US HOLDINGS |
Labeling |
Approval |
08/30/2018 |
FLECTOR NDA #021234 |
SUPPL-15 |
DICLOFENAC EPOLAMINE |
IBSA |
Labeling |
Approval |
08/30/2018 |
HYDROCODONE BITARTRATE AND IBUPROFEN ANDA #076023 |
SUPPL-17 |
HYDROCODONE BITARTRATE; IBUPROFEN |
TEVA |
Labeling |
Approval |
08/30/2018 |
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL ANDA #205131 |
SUPPL-1 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
XIROMED |
Labeling |
Approval |
08/30/2018 |
DILTIAZEM HYDROCHLORIDE ANDA #205231 |
ORIG-1 |
DILTIAZEM HYDROCHLORIDE |
TWI PHARMS |
|
Approval |
08/30/2018 |
EFAVIRENZ ANDA #205322 |
ORIG-1 |
EFAVIRENZ |
AUROBINDO PHARMA |
|
Approval |
08/30/2018 |
DAPTOMYCIN NDA #208385 |
SUPPL-1 |
DAPTOMYCIN |
SAGENT PHARMS INC |
Labeling |
Approval |
08/30/2018 |
AMLODIPINE AND OLMESARTAN MEDOXOMIL ANDA #209600 |
ORIG-1 |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
ACCORD HLTHCARE INC |
|
Approval |
08/30/2018 |
PIFELTRO NDA #210806 |
ORIG-1 |
DORAVIRINE |
MSD MERCK CO |
Type 1 - New Molecular Entity |
Approval |
08/30/2018 |
DELSTRIGO NDA #210807 |
ORIG-1 |
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE |
MSD MERCK CO |
Type 4 - New Combination |
Approval |
08/31/2018 |
ADVIL LIQUI-GELS NDA #020402 |
SUPPL-47 |
IBUPROFEN |
HALEON US HOLDINGS |
Labeling |
Approval |
08/31/2018 |
ADVIL MIGRAINE LIQUI-GELS NDA #020402 |
SUPPL-47 |
IBUPROFEN |
HALEON US HOLDINGS |
Labeling |
Approval |
08/31/2018 |
ABSORICA NDA #021951 |
SUPPL-14 |
ISOTRETINOIN |
SUN PHARM INDS INC |
Labeling |
Approval |
08/31/2018 |
AMNESTEEM ANDA #075945 |
SUPPL-37 |
ISOTRETINOIN |
MYLAN PHARMS INC |
Labeling |
Approval |
08/31/2018 |
CLARAVIS ANDA #076135 |
SUPPL-43 |
ISOTRETINOIN |
TEVA PHARMS USA |
Labeling |
Approval |
08/31/2018 |
CLARAVIS ANDA #076356 |
SUPPL-40 |
ISOTRETINOIN |
TEVA PHARMS USA |
Labeling |
Approval |
08/31/2018 |
MYORISAN ANDA #076485 |
SUPPL-21 |
ISOTRETINOIN |
UPSHER SMITH LABS |
Labeling |
Approval |
08/31/2018 |
BETASERON BLA #103471 |
SUPPL-5193 |
INTERFERON BETA-1B |
BAYER HEALTHCARE PHARMS |
|
Approval |
08/31/2018 |
ZENATANE ANDA #202099 |
SUPPL-15 |
ISOTRETINOIN |
DR REDDYS LABS LTD |
Labeling |
Approval |
08/31/2018 |
XOFIGO NDA #203971 |
SUPPL-14 |
RADIUM RA-223 DICHLORIDE |
BAYER HLTHCARE |
Labeling |
Approval |
08/31/2018 |
BELRAPZO NDA #205580 |
SUPPL-2 |
BENDAMUSTINE HYDROCHLORIDE |
EAGLE PHARMS |
Labeling |
Approval |
08/31/2018 |
ACYCLOVIR SODIUM ANDA #206535 |
ORIG-1 |
ACYCLOVIR SODIUM |
ZYDUS PHARMS |
|
Approval |
08/31/2018 |
ISOTRETINOIN ANDA #207792 |
SUPPL-5 |
ISOTRETINOIN |
AMNEAL PHARMS NY |
Labeling |
Approval |
08/31/2018 |
ARSENIC TRIOXIDE ANDA #208231 |
ORIG-1 |
ARSENIC TRIOXIDE |
FRESENIUS KABI USA |
|
Approval |
08/31/2018 |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE ANDA #210571 |
ORIG-1 |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
UPSHER SMITH LABS |
|
Approval |
08/31/2018 |
POTASSIUM CHLORIDE ANDA #210733 |
ORIG-1 |
POTASSIUM CHLORIDE |
STRIDES PHARMA |
|
Approval |